507 related articles for article (PubMed ID: 978044)
1. Plasmic degradation of fibrinogen Paris I.
Budzynski AZ; Marder VJ
J Lab Clin Med; 1976 Nov; 88(5):817-25. PubMed ID: 978044
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte suppressive peptides from fibrinogen are derived predominantly from the A alpha chain.
Plow EF; Edgington TS
J Immunol; 1986 Sep; 137(6):1910-5. PubMed ID: 2943807
[TBL] [Abstract][Full Text] [Related]
3. Orientation of the carboxy-terminal regions of fibrin gamma chain dimers determined from the crosslinked products formed in mixtures of fibrin, fragment D, and factor XIIIa.
Siebenlist KR; Meh DA; Wall JS; Hainfeld JF; Mosesson MW
Thromb Haemost; 1995 Oct; 74(4):1113-9. PubMed ID: 8560422
[TBL] [Abstract][Full Text] [Related]
4. Studies on the structural abnormality of fibrinogen Paris I.
Mosesson MW; Amrani DL; Ménaché D
J Clin Invest; 1976 Mar; 57(3):782-90. PubMed ID: 1249208
[TBL] [Abstract][Full Text] [Related]
5. Plasma and platelet fibrinogen differ in gamma chain content.
Francis CW; Nachman RL; Marder VJ
Thromb Haemost; 1984 Feb; 51(1):84-8. PubMed ID: 6719392
[TBL] [Abstract][Full Text] [Related]
6. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
[TBL] [Abstract][Full Text] [Related]
7. [Chemical properties of plasma fibrinogens and fibrins from normal and cobalt-treated rabbits].
Lober M; Krantz S
Acta Biol Med Ger; 1975; 34?710():1573-88. PubMed ID: 1233845
[TBL] [Abstract][Full Text] [Related]
8. Terminal plasmin degradation products D and E of duck fibrinogen and their effect on polymerization of fibrin.
Krajewski T; Nowak P; Cierniewski C
Acta Biochim Pol; 1985; 32(2):144-54. PubMed ID: 4036448
[TBL] [Abstract][Full Text] [Related]
9. The role of soluble cross-linked fibrin in D dimer immunoreactivity of plasmic digests.
Brenner B; Francis CW; Marder VJ
J Lab Clin Med; 1989 Jun; 113(6):682-8. PubMed ID: 2732616
[TBL] [Abstract][Full Text] [Related]
10. Normal binding of calcium to five fibrinogen variants with mutations in the carboxy terminal part of the gamma-chain.
Furlan M; Stucki B; Steinmann C; Jungo M; Lämmle B
Thromb Haemost; 1996 Sep; 76(3):377-83. PubMed ID: 8883274
[TBL] [Abstract][Full Text] [Related]
11. Heterozygous abnormal fibrinogen Osaka III with the replacement of gamma arginine-275 by histidine has an apparently higher molecular weight gamma-chain variant.
Yoshida N; Imaoka S; Hirata H; Matsuda M; Asakura S
Thromb Haemost; 1992 Nov; 68(5):534-8. PubMed ID: 1455400
[TBL] [Abstract][Full Text] [Related]
12. [The antifibrinolytic action of the D-dimer fragment].
Rozenfel'd MA; Khavkina LS; Leonova VB; Gershkovich KB; Vasil'eva MV
Izv Akad Nauk SSSR Biol; 1989; (6):855-61. PubMed ID: 2621282
[TBL] [Abstract][Full Text] [Related]
13. Fibrin and fibrinogen proteolysis products: comparison between gel filtration and SDS polyacrylamide electrophoresis analysis.
Alkjaersig N; Davies A; Fletcher A
Thromb Haemost; 1977 Aug; 38(2):524-5. PubMed ID: 145666
[TBL] [Abstract][Full Text] [Related]
14. Degradation of cross-linked fibrin by human leukocyte proteases.
Francis CW; Marder VJ
J Lab Clin Med; 1986 Apr; 107(4):342-52. PubMed ID: 3514776
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen degradation by hementin, a fibrinogenolytic anticoagulant from the salivary glands of the leech Haementeria ghilianii.
Malinconico SM; Katz JB; Budzynski AZ
J Lab Clin Med; 1984 Nov; 104(5):842-54. PubMed ID: 6387015
[TBL] [Abstract][Full Text] [Related]
16. Defective alpha-polymerization in the conversion of fibrinogen Baltimore to fibrin.
Brown CH; Crowe MF
J Clin Invest; 1975 Jun; 55(6):1190-4. PubMed ID: 1133167
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the physicochemical properties of fragment D derivatives of fibrinogen and fragment D-D of cross-linked fibrin.
Marder VJ; Budzynski AZ; Barlow GH
Biochim Biophys Acta; 1976 Mar; 427(1):1-14. PubMed ID: 130927
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the cross-linking patterns of lamprey fibrinogen and fibrin by the action of the intrinsic lamprey factor XIII and human factor XIII during the process of blood coagulation.
Murtaugh PA
Thromb Haemost; 1977 Aug; 38(2):429-37. PubMed ID: 579486
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of cross-linked fibrin and fibrinogen degradation products with SDS-PAGE and immunoblot].
Okumura N; Kagiya H; Kumagai T; Kameko M; Tozuka M; Saito H; Katsuyama T; Kanai M
Rinsho Byori; 1990 Feb; 38(2):201-7. PubMed ID: 2329722
[TBL] [Abstract][Full Text] [Related]
20. Degradation pathway of fibrinogen by plasmin.
Budzynski AZ; Marder VJ
Thromb Haemost; 1977 Dec; 38(4):793-800. PubMed ID: 146273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
